Your Cart ( 1 Item )

• Phase IV, Open-Label Assessment of the Treatment of Actinic Keratosis With 3.0% Diclofenac Sodium Topical Gel (Solaraze™)
  July 2004 | Volume 3 | Issue 4 | Original Article | 401 | Copyright © July 2004
  Darrell Rigel MD, Christopher Nelson MD, Stacy Smith MD, Neil Swanson MD, John Wolf, MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs